Secretory Leukocyte Protease Inhibitor Inhibits Infection of Monocytes and Lymphocytes with Human Immunodeficiency Virus Type 1 but Does Not Interfere with Transcytosis of Cell-Associated Virus across Tight Epithelial Barriers

In the present study, we demonstrate that recombinant human secretory leukocyte protease inhibitor (rhSLPI) inhibits infection of lymphocyte- and monocyte-derived tumor cell lines and peripheral blood lymphocytes with laboratory-adapted isolates and with the primary isolate, NDK, of free human immun...

Ful tanımlama

Detaylı Bibliyografya

Yayımlandı:	Clin Diagn Lab Immunol
Asıl Yazarlar:	Hocini, Hakim, Becquart, Pierre, Bouhlal, Hicham, Adle-Biassette, Homa, Kazatchkine, Michel D., Bélec, Laurent
Materyal Türü:	Artigo
Dil:	Inglês
Baskı/Yayın Bilgisi:	American Society for Microbiology (ASM) 2000
Konular:	Cellular Immunology
Online Erişim:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC95905/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/10799472/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/cdli.7.3.515-518.2000
Etiketler:	Etiketle Etiket eklenmemiş, İlk siz ekleyin!